A Study of JNS020QD in Patients With Chronic Pain

NCT01493245 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Pain

Interventions

DRUG: JNS020QD

Sponsor

Janssen Pharmaceutical K.K.